WTX beyond WNT signaling pathway
Visualized Cancer Medicine · 2023
DOI: 10.1051/vcm/2022006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Visualized Cancer Medicine, 2023. Verfasst von Qingling Zhang und 3 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gastric cancer (GC) is a major malignancy in many developing countries with low early detection rate. As a tumour suppressor gene, WTX inhibits PI3K/AKT/mTOR pathway activity by inhibiting PI3K phosphorylation. WTX loss of WTX protein associates with tumor metastasis and poor survival of GC patients. During GC progression, an aberrantly elevated miR-20a-5p expression has been found, which inhibits WTX expression and induces PI3K phosphorylation, thereby activating the PI3K/AKT/mTOR pathway and promoting cellular proliferation and migration. A new mechanism in which miR-20a-5p promotes GC progression by regulating WTX expression to control PI3K/AKT/mTOR pathway activity has been recently discovered. These findings might be useful for developing novel therapeutics to inhibit the progression of GC.
Zitieren
APA
Zhang, Q., Hu, Q., Li, J., & Lin, Z. (2023). WTX beyond WNT signaling pathway. Visualized Cancer Medicine. https://doi.org/10.1051/vcm/2022006
Vancouver
Zhang Q, Hu Q, Li J, Lin Z. WTX beyond WNT signaling pathway. Visualized Cancer Medicine. 2023. doi:10.1051/vcm/2022006
BibTeX
@article{Zhang2023,
author = {Zhang, Qingling and Hu, Qi and Li, Jian and Lin, Zhirui},
title = {WTX beyond WNT signaling pathway},
journal = {Visualized Cancer Medicine},
year = {2023},
doi = {10.1051/vcm/2022006}
}
EUVIMED